Alverini citras 60 mg and simeticonum 300 mg in 1 capsule
Meteospasmyl is a combined preparation containing alverine, a spasmolytic agent with a direct effect on the smooth muscle of the digestive tract. Alverine is more effective than papaverine and exerts fewer undesirable effects. The second component of the preparation is simethicone, which by a physical mechanism decreases the formation of gas and facilitates its removal from the digestive tract.
Spasmolytic agent, deflatulent (ATC code: A03AX58)
Symptomatic treatment of functional intestinal disorders accompanied by abdominal pains or even painful spasms, compulsive diarrhoea, meteorism and flatulence. Particularly, the irritable colon is concerned. The preparation is intended only for adults.
Hypersensitivity to any component of the preparation, ileus conditions, pregnancy and lactation, children and adolescents under 18 years of age.
Meteospasmyl is usually very well tolerated, undesirable effects are sporadic and transitory. In the course of treatment, headache, dry mouth, nausea, weakness, vertigo, and decreased blood pressure may occur. Very rarely allergic skin rash may develop.
No interactions of Meteospasmyl with other drugs have been reported.
Caution is required when signs preceding ileus (nausea, vomiting, abdominal pains, blocking of wind and stool) occur.
Usually 1 capsule is administered 2 to 3 times a day before meals, for a period of 3 to 4 weeks. Capsules are swallowed whole, unchewed, and are washed down with a sufficient amount of liquid.
For more detailed product information, see the Summary of Product Characteristics.